Centessa Pharmaceuticals PLC (CNTA) — 10-Q Filings

All 10-Q filings from Centessa Pharmaceuticals PLC. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Centessa's Q3 Loss Widens Amid R&D Surge, Cash Drains — Nov 5, 2025 Risk: high
Centessa Pharmaceuticals plc reported a net loss of $54.89 million for the three months ended September 30, 2025, an increase from a net loss of $42.57 million
Centessa's Q2 Loss Widens Amid Soaring R&D Costs — Aug 12, 2025 Risk: high
Centessa Pharmaceuticals plc reported a net loss of $50.343 million for the three months ended June 30, 2025, an increase from the $43.816 million net loss in t
Centessa Pharmaceuticals Q1 2025 10-Q Filing — May 14, 2025 Risk: medium
Centessa Pharmaceuticals plc filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first
Centessa Pharmaceuticals Q3 2024 10-Q Filing — Nov 12, 2024 Risk: medium
Centessa Pharmaceuticals plc filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the t
Centessa Pharmaceuticals Files Q2 2024 10-Q — Aug 13, 2024 Risk: low
Centessa Pharmaceuticals plc filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The company's fiscal year ends on Decem
Centessa Pharmaceuticals plc Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: medium
Centessa Pharmaceuticals plc (CNTA) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Centessa Pharmaceuticals plc filed a 10-Q report for the perio

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX